News Outlets Report On Latest Developments In COVID-19 Vaccine, Diagnostic Research

Bloomberg: Delays Hit Oxford Vaccine Production for U.K. Government Supply (Morales/Patton, 11/4).

Bloomberg: England Puts Doctors on Alert for Covid Vaccine Before Christmas (Ashton, 11/4).

Financial Times: U.K. spends £1bn on Boris Johnson’s rapid coronavirus testing ‘moonshot’ (Gross/Bott, 11/3).

The Guardian: Rich states’ Covid deals ‘may deprive poor of vaccine for years’ (Safi, 11/3).

Reuters: Oxford COVID-19 vaccine results due next month, raising hopes of 2021 rollout (Smout/Faulconbridge, 11/4).

Science: Will a small, long-shot U.S. company end up producing the best coronavirus vaccine? (Wadman, 11/3).

South China Morning Post: Coronavirus: international funding boost for Chinese vaccine maker Clover (McCarthy, 11/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.